Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pulse Biosciences (PLSE) Accumulated Depreciation & Amortization (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Accumulated Depreciation & Amortization data on record, last reported at $4.3 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 10.68% year-over-year to $4.3 million; the TTM value through Sep 2025 reached $4.3 million, up 10.68%, while the annual FY2024 figure was $4.0 million, 14.15% up from the prior year.
  • Accumulated Depreciation & Amortization reached $4.3 million in Q3 2025 per PLSE's latest filing, up from $4.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $4.3 million in Q3 2025 and bottomed at $2.0 million in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $3.1 million, with a median of $3.0 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: increased 28.74% in 2022, then increased 10.68% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $2.4 million in 2021, then increased by 23.25% to $3.0 million in 2022, then rose by 17.71% to $3.5 million in 2023, then grew by 14.15% to $4.0 million in 2024, then rose by 7.89% to $4.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $4.3 million in Q3 2025, $4.0 million in Q4 2024, and $3.9 million in Q3 2024.